UV-C lighting has been a key tool in disinfection for many years, but its use has been limited due to potential harm to humans from prolonged exposure. However, recent advancements in UV-C technology have led to the development of a new type of UV-C lighting that is safe for human exposure: Care222 Far-UVC.
Far-UVC lighting operates at a wavelength of 222 nanometers (nm), which is much shorter than the wavelengths used in traditional UV-C lighting. This shorter wavelength means that the light can only penetrate the outermost layer of skin, preventing harm to humans while still being effective in killing viruses and bacteria.
Studies have shown that Care222 Far-UVC lighting can effectively inactivate airborne viruses, including the SARS-CoV-2 virus responsible for the COVID-19 pandemic. In fact, research has shown that even low doses of Care222 Far-UVC lighting can significantly reduce the airborne transmission of the virus in enclosed spaces.
In addition to its effectiveness against viruses and bacteria, Care222 Far-UVC lighting also offers several advantages over traditional UV-C lighting. For one, it is safer for human exposure, allowing for its use in public spaces and other areas where people may be present. It also has a longer lifespan than traditional UV-C lighting and requires less energy, making it more cost-effective in the long run.
Care222 Far-UVC lighting is already being used in a variety of applications, including in hospitals, schools, and public transportation systems. It has also been approved by the US Food and Drug Administration (FDA) for use in disinfecting certain indoor spaces.
As we continue to face the challenges of the COVID-19 pandemic and other infectious diseases, Care222 Far-UVC lighting offers a promising solution for safer and more effective disinfection. Its ability to kill viruses and bacteria while remaining safe for human exposure make it a valuable tool for public health and safety.